• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重的预测价值。

Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease.

作者信息

Karadeniz Gülistan, Aktoğu Serir, Erer Onur Fevzi, Kır Serpil Bulaç, Doruk Sibel, Demir Melike, Sonat Kübra

机构信息

Dr Suat Seren Chest Disease & Surgery Training & Research Hospital, Department of Pulmonology, Izmir, Turkey.

Sifa University School of Medicine, Department of Pulmonology, Izmir, Turkey.

出版信息

Biomark Med. 2016 Jul;10(7):701-10. doi: 10.2217/bmm-2016-0046. Epub 2016 Jun 24.

DOI:10.2217/bmm-2016-0046
PMID:27339097
Abstract

AIM

We aimed to assess the platelet-to-lymphocyte ratio (PLR) and platelet parameters in patients with chronic obstructive pulmonary disease (COPD).

METHODS

A total of 60 stable COPD patients, 50 acute exacerbation COPD patients and 50 healthy controls were enrolled in this study.

RESULTS

The platelet distribution width and PLR were higher and the mean platelet volume was lower in the COPD patients during acute exacerbation compared with the stable patients and controls. The PLR was negatively correlated with the forced expiratory volume in 1 s.

CONCLUSION

The PLR may be used as a useful and easily accessible tool for evaluating the ongoing inflammation during stable period and the disease severity during acute exacerbations in COPD patients.

摘要

目的

我们旨在评估慢性阻塞性肺疾病(COPD)患者的血小板与淋巴细胞比值(PLR)及血小板参数。

方法

本研究共纳入60例稳定期COPD患者、50例急性加重期COPD患者及50例健康对照者。

结果

与稳定期患者及对照组相比,急性加重期COPD患者的血小板分布宽度及PLR较高,而平均血小板体积较低。PLR与第1秒用力呼气量呈负相关。

结论

PLR可作为评估COPD患者稳定期炎症及急性加重期疾病严重程度的有用且易于获取的工具。

相似文献

1
Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease.血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重的预测价值。
Biomark Med. 2016 Jul;10(7):701-10. doi: 10.2217/bmm-2016-0046. Epub 2016 Jun 24.
2
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及单核细胞与淋巴细胞比值(MLR)作为慢性阻塞性肺疾病急性加重诊断评估的生物标志物:一项回顾性观察研究
Int J Chron Obstruct Pulmon Dis. 2024 Apr 15;19:933-943. doi: 10.2147/COPD.S452444. eCollection 2024.
3
The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.平均血小板体积在慢性阻塞性肺疾病急性加重中的作用
Respir Care. 2016 Jan;61(1):44-9. doi: 10.4187/respcare.04132. Epub 2015 Nov 24.
4
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重患者院内死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.
5
The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.中性粒细胞/淋巴细胞比值作为 COPD 感染的标志物,优于 CD64 指数,是 C-反应蛋白的更好补充。
Panminerva Med. 2017 Sep;59(3):203-209. doi: 10.23736/S0031-0808.17.03296-7. Epub 2017 Feb 9.
6
Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.平均血小板体积在慢性阻塞性肺疾病急性加重期降低。
Respirology. 2013 Nov;18(8):1244-8. doi: 10.1111/resp.12143.
7
Platelet indices in stable chronic obstructive pulmonary disease - association with inflammatory markers, comorbidities and therapy.稳定期慢性阻塞性肺疾病的血小板指数 - 与炎症标志物、合并症和治疗的关系。
Biochem Med (Zagreb). 2020 Feb 15;30(1):010701. doi: 10.11613/BM.2020.010701. Epub 2019 Dec 15.
8
The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.炎症标志物在预测伴或不伴嗜酸性粒细胞增多的慢性阻塞性肺疾病(COPD)病例再入院率和死亡率方面的效用。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 11;10:2469-78. doi: 10.2147/COPD.S90330. eCollection 2015.
9
Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者病情稳定期和急性加重期中性粒细胞与淋巴细胞比值的变化
Clin Respir J. 2017 May;11(3):311-317. doi: 10.1111/crj.12336. Epub 2015 Aug 6.
10
A score to predict short-term risk of COPD exacerbations (SCOPEX).一种预测慢性阻塞性肺疾病急性加重短期风险的评分(SCOPEX)。
Int J Chron Obstruct Pulmon Dis. 2015 Jan 27;10:201-9. doi: 10.2147/COPD.S69589. eCollection 2015.

引用本文的文献

1
Association of CALLY index and CLR with COPD risk in middle-aged and older Americans: evidence from NHANES 2017-2020.CALLY指数和CLR与美国中老年人慢性阻塞性肺疾病风险的关联:来自2017 - 2020年美国国家健康与营养检查调查的证据
Front Med (Lausanne). 2025 Apr 17;12:1535415. doi: 10.3389/fmed.2025.1535415. eCollection 2025.
2
Evaluation of the prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbation of chronic obstructive pulmonary disease.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在慢性阻塞性肺疾病急性加重期的预后价值评估
J Res Med Sci. 2022 Jul 29;27:50. doi: 10.4103/jrms.JRMS_512_20. eCollection 2022.
3
Procalcitonin kinetics to guide sequential invasive-noninvasive mechanical ventilation weaning in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: procalcitonin's adjunct role.
降钙素原动力学指导慢性阻塞性肺疾病急性加重合并呼吸衰竭患者有创-无创序贯机械通气撤机:降钙素原的辅助作用。
Libyan J Med. 2021 Dec;16(1):1961382. doi: 10.1080/19932820.2021.1961382.
4
Predictive value of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hypersensitivity pneumonia.血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值对过敏性肺炎患者的预测价值。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020012. doi: 10.36141/svdld.v37i4.9966. Epub 2020 Dec 16.
5
The Relationship of Lymphocyte to High-Density Lipoprotein Ratio with Pulmonary Function in COPD.淋巴细胞与高密度脂蛋白比值与 COPD 患者肺功能的关系。
Int J Chron Obstruct Pulmon Dis. 2020 Dec 1;15:3159-3169. doi: 10.2147/COPD.S276372. eCollection 2020.
6
Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.常规血液生物标志物与慢性阻塞性肺疾病的临床表型和加重的关系。
Int J Chron Obstruct Pulmon Dis. 2020 Mar 31;15:681-690. doi: 10.2147/COPD.S240720. eCollection 2020.
7
Feasibility of mean platelet volume as a biomarker for chronic obstructive pulmonary disease: A systematic review and meta-analysis.平均血小板体积作为慢性阻塞性肺疾病生物标志物的可行性:一项系统评价和荟萃分析。
J Int Med Res. 2019 Dec;47(12):5937-5949. doi: 10.1177/0300060519887886. Epub 2019 Nov 27.
8
Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study.慢性阻塞性肺疾病稳定期和急性加重期患者的血清生物标志物:一项比较研究。
J Med Biochem. 2019 Jan 22;38(4):503-511. doi: 10.2478/jomb-2018-0050. eCollection 2019 Oct.
9
The prognostic values of neutrophil to lymphocyte ratio for outcomes in chronic obstructive pulmonary disease.中性粒细胞与淋巴细胞比值对慢性阻塞性肺疾病预后的价值
Medicine (Baltimore). 2019 Jul;98(28):e16371. doi: 10.1097/MD.0000000000016371.
10
Platelet distribution width as a prognostic factor in patients with COPD - pilot study.血小板分布宽度作为慢性阻塞性肺疾病患者的预后因素——初步研究
Int J Chron Obstruct Pulmon Dis. 2017 Aug 1;12:2261-2267. doi: 10.2147/COPD.S131868. eCollection 2017.